Wed, Sep 17, 2014, 1:27 PM EDT - U.S. Markets close in 2 hrs 33 mins

Recent

% | $
Quotes you view appear here for quick access.

MannKind Corp. Message Board

  • kevinmik kevinmik Aug 17, 2013 8:28 PM Flag

    Partnership Choice For Afrezza Also Impacts Technosphere Future Drug Candidates Success

    Al knows he needs a good partner for Afrezza to ensure the drugs commercial success, which in turn will also open the door and lay the ground work for future drugs that will be using Technosphere Technology and Mannkind's novel Delivery Devices to be successful.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I know you feel like you are talking to a brick wall but I hear you. Some people can't think out of the box. That said, if Al sells the company, I'm not sure he'll care about what happens with the technology. We'll see.

      • 1 Reply to factspls88
      • I think he definitely cares and will carefully weed out those company's whether its a partnership or buyout that have conflict of interests keeping them from putting all their efforts and resources behind Afrezza and Technosphere to ensure their success. That's why I believe Roche would make a good partner. I was leaning towards Pfizer, but Al may feel they are too big and that Afrezza will be just another fish in their fish tank. He also has seen how easily Pfizer walks away from partnership deals as they did with Exubera and Biocon.

 
MNKD
6.28+0.09(+1.37%)1:27 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.